Financials

  • Market Capitalization 226.2 M
  • Employee 130
  • Founded 2016
  • CEO N/A
  • Website www.nautilus.bio
  • Headquarter Washington, United States
  • FIGI BBG00W7G4M12
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.15
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3530
AGEN
Agenus Inc. - Common Stock
5.24 USD-14.38%+48.44%+55.95%-23.62%218.21 M USD
3533
IVVD
Invivyd, Inc. - Common Stock
0.80 USD+1.27%-17.53%-1.23%+11.11%235.69 M USD
3552
OBIO
Orchestra BioMed Holdings, Inc. - Ordinary Shares
3.76 USD-1.57%-5.76%-8.74%+23.68%225.15 M USD
3557
CHRS
Coherus Oncology, Inc. - Common Stock
1.45 USD-1.36%-13.69%+1.40%-9.94%223.66 M USD

Notizie